Status:
NOT_YET_RECRUITING
Learning Theory Patient Education for Anticoagulants
Lead Sponsor:
University of Utah
Collaborating Sponsors:
National Heart, Lung, and Blood Institute (NHLBI)
Conditions:
Knowledge, Attitudes, Practice
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
The goal of this study is to test the feasibility of a randomized control trial evaluating the educational tool for anticoagulated patients. Participants will be randomized to use new educational mat...
Detailed Description
Eligible patients will be randomized using stratified block randomization to control for the type of anticoagulant (warfarin vs. DOAC) and status (naïve vs. experienced) to either the education interv...
Eligibility Criteria
Inclusion
- initiating (naïve) or currently taking (experienced) oral anticoagulants with an anticipated treatment duration of at least three months
- Experienced patients will be eligible if they score less than 75% on the Anticoagulation Knowledge Test
Exclusion
- Deficits in cognitive abilities, sensory input, or language significant enough to impede their use of the education tool and/or provision of written informed consent
Key Trial Info
Start Date :
April 1 2026
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 1 2026
Estimated Enrollment :
68 Patients enrolled
Trial Details
Trial ID
NCT06138184
Start Date
April 1 2026
End Date
December 1 2026
Last Update
December 17 2025
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.